Pre-existing low-frequency resistance mutations increase the risk of antiretroviral treatment failure in HIV-1 naïve patients

Impact of pre-existing drug resistance on risk of virological failure in South Africa

(2021) Jonathan Z Li et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

RNA and DNA Sanger sequencing versus next-generation sequencing for HIV-1 drug resistance testing in treatment-naive patients

(2017) E K Alidjinou et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial

(2015) Rami Kantor et al.   CLINICAL INFECTIOUS DISEASES

Clinical Implications of HIV-1 Minority Variants

(2013) Jonathan Z. Li et al.   CLINICAL INFECTIOUS DISEASES

A tale of three next generation sequencing platforms: comparison of Ion torrent, pacific biosciences and illumina MiSeq sequencers

(2012) Michael Quail et al.   BMC GENOMICS

Low-Frequency HIV-1 Drug Resistance Mutations and Risk of NNRTI-Based Antiretroviral Treatment Failure

(2011) Jonathan Z. Li   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Minority Variants of Drug‐Resistant HIV

(2010) Sara Gianella et al.   JOURNAL OF INFECTIOUS DISEASES